Astrazeneca Pharma I - Quarterly Results
11th Nov 2019

The Sales for the quarter ended September 2019 of Rs. 2084.83 millions rose by 29.20% from Rs. 1613.61 millions.Net profit for the quarter ended September 2019 increased significantly by 57.83% to Rs. 144.15 millions from Rs. 91.33 millions.Operating profit for the quarter ended September 2019 rose to 367.21 millions as compared to 181.19 millions of corresponding quarter ended September 2018.



(Rs. in Million)


  Quarter ended Year to Date Year ended
  201909 201809 % Var 201909 201809 % Var 201903 201803 % Var
Sales 2084.83 1613.61 29.20 4130.44 3227.98 27.96 7282.94 5719.89 27.33
Other Income 31.61 33.55 -5.78 61.50 67.78 -9.27 162.85 122.48 32.96
PBIDT 367.21 181.19 102.67 752.72 308.21 144.22 875.88 585.38 49.63
Interest 2.84 0.00 0.00 5.79 0.00 0.00 0.00 0.00 0.00
PBDT 364.37 181.19 101.10 746.93 308.21 142.34 875.88 585.38 49.63
Depreciation 46.41 36.74 26.32 92.68 72.24 28.29 149.24 147.38 1.26
PBT 317.96 144.45 120.12 654.25 235.97 177.26 726.64 438.00 65.90
TAX 173.81 53.12 227.20 294.95 80.71 265.44 182.23 178.85 1.89
Deferred Tax 122.34 9.33 1211.25 116.52 10.57 1002.37 15.45 88.88 -82.62
PAT 144.15 91.33 57.83 359.30 155.26 131.42 544.41 259.15 110.08
Equity 50.00 50.00 0.00 50.00 50.00 0.00 50.00 50.00 0.00
PBIDTM(%) 17.61 11.23 56.86 18.22 9.55 90.86 12.03 10.23 17.51